Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation
To investigate the value of tumor feeding vessels deprivation combined with tyrosine kinase inhibitor in liver transplantation. Patients are enrolled into two groups according to the downstaging therapy they undergo before transplantion.
Liver Transplantation
COMBINATION_PRODUCT: PVHA or TACE
Underwent LT, Underwent LT, January 2013 and December 2020|Successful downstaging, Successful downstaging, January 2013 and December 2020
AFP reduction of patients, AFP reduction of patients, January 2013 and December 2020|Survival time of patients, Survival time of patients, January 2013 and December 2020|Recurrence of patients, Recurrence of patients, January 2013 and December 2020
To investigate the value of tumor feeding vessels deprivation combined with tyrosine kinase inhibitor in liver transplantation. Patients are enrolled into two groups according to the downstaging therapy they undergo before transplantion.